Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2021 June;73(3) > Minerva Urology and Nephrology 2021 June;73(3):404-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Urology and Nephrology 2021 June;73(3):404-6

DOI: 10.23736/S2724-6051.20.04197-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic

Wei-Shen TAN 1, 2, 3, Maya MARCHESE 3, 4, Marco PACIOTTI 3, 4, David-Dan NGUYEN 3, 4, Eugene B. CONE 3, 4, Matthew MOSSANEN 3, 4, 5, John J. WEBSTER 2, Ravi BAROD 6, Axel BEX 1, 6, Adam S. KIBEL 3, 5, Steven L. CHANG 3, 5, Quoc-Dien TRINH 3, 4, 5

1 Division of Surgery and Interventional Science, University College London, London, UK; 2 Department of Urology, Northwick Park Hospital, London, UK; 3 Division of Urological Surgery, Brigham and Women’s Hospital, Boston, MA, USA; 4 Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, USA; 5 Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 6 The Specialist Center for Kidney Cancer, Royal Free Hospital, London, UK



inizio pagina